Monitoring Requirements Combining these therapies requires careful lab monitoring, including: Total and free testosterone levels Estradiol (to ensure proper aromatase balance) Complete blood count (TRT can increase hematocrit) Metabolic panel (fasting glucose, HbA1c, lipids) PSA (prostate-specific antigen) Liver and kidney function Thyroid function Labs should be checked at baseline, at 6-8 weeks after initiation, and then every 3-6 months during ongoing treatment
Both components are also available separately: BPC-157 and TB-500
Shepherd, F
Ten years ago, we estimate that there were 100 sterile compounding pharmacies in California, and now we only have 18 left because they had to close down because they cant abide by theseregulations that arent the same in the other states. Due to pushback from the public and some uncertainty amongst board members, the board decided to hold off on further action until their September 12 board meeting
C., and Van der Heiden, M
In stage 4 , kidney damage and loss of function are severe, as reflected by a low eGFR of 1529
